ARAF and MYO18A

Number of citations of the paper that reports this interaction (PubMedID 20936779)
85

Data Source:
BioGRID (two hybrid)

		ARAF	MYO18A
Description		A-Raf proto-oncogene, serine/threonine kinase	myosin XVIIIA
Image			No pdb structure
GO Annotations	Cellular Component	Cellular_component Mitochondrion Cytosol	Golgi Membrane Endoplasmic Reticulum-Golgi Intermediate Compartment Trans-Golgi Network Cell Surface Membrane Myosin Complex Cell Junction Actomyosin Postsynaptic Golgi Apparatus
	Molecular Function	Protein Kinase Activity Protein Serine/threonine Kinase Activity Protein Binding ATP Binding Metal Ion Binding	DNA Binding RNA Binding Protein Binding ATP Binding ATPase Activity ADP Binding Actin Filament Binding
	Biological Process	MAPK Cascade Cellular Protein Modification Process Regulation Of TOR Signaling Regulation Of Proteasomal Ubiquitin-dependent Protein Catabolic Process Positive Regulation Of Peptidyl-serine Phosphorylation Negative Regulation Of Apoptotic Process	DNA Metabolic Process Golgi Organization Cell Migration Actomyosin Structure Organization Regulation Of Macrophage Activation Negative Regulation Of Apoptotic Process Golgi Vesicle Budding Positive Regulation Of Protein Secretion Golgi Ribbon Formation Asymmetric Golgi Ribbon Formation Positive Regulation Of Opsonization
Pathways		RAF activation MAP2K and MAPK activation Negative regulation of MAPK pathway Signaling by moderate kinase activity BRAF mutants Signaling by high-kinase activity BRAF mutants Signaling by BRAF and RAF fusions Paradoxical activation of RAF signaling by kinase inactive BRAF Signaling downstream of RAS mutants	Signaling by cytosolic FGFR1 fusion mutants Signaling by FGFR1 in disease
Drugs		ATP
Diseases		Noonan syndrome and related disorders, including: Noonan syndrome (NS); Leopard syndrome (LS); Noonan syndrome-like with loose anagen hair (NS/LAH); CBL-mutation associated syndrome (CBL); Neurofibromatosis type 1 (NF1); Neurofibromatosis type 2 (NF2); Neurofibromatosis-Noonan syndrome (NFNS); Legius syndrome; Cardiofaciocutaneous syndrome (CFCS); Costello syndrome (CS)
GWAS			anorexia nervosa, attention-deficit/hyperactivity disorder, autism spectrum disorder, bipolar disorder, major depression, obsessive-compulsive disorder, schizophrenia, or Tourette syndrome (pleiotropy) ( 31835028) Depression ( 29700475) Night sleep phenotypes ( 27126917) Sitting height ratio ( 25865494) Smoking behaviour (cigarette pack-years) ( 30679032)
Interacting Genes		59 interacting genes: AGTRAP AKT1 ASS1 BAD BECN1 BRAF CCND2 CDK4 CDK6 CDKN2B CHD6 COPS3 CPS1 CSNK2B DIDO1 E2F6 EFEMP1 EPHA2 FGFR4 GLIS2 GNA12 HRAS IRAK2 IRF7 KLHL12 KRAS LATS2 MAP2K1 MAP2K2 MAP2K3 MAP2K5 MLH1 MYC MYO18A NELFCD NF2 NUDT14 PBK PDGFRB PIK3CA PIK3R1 PKM PRPF6 RABGGTB RASSF1 RGS12 RRAS RRAS2 SFN STK11 TEKT4P2 TESK1 TIMM44 TIRAP TP53 TSC1 WNK1 YWHAG YWHAZ	3 interacting genes: ARAF ATXN1 GRB2
Entrez ID		369	399687
HPRD ID		02405	10106
Ensembl ID		ENSG00000078061	ENSG00000196535
Uniprot IDs		A0A024R178 P10398 Q96II5	A0A024QZ63 Q92614 Q9NYE8
PDB IDs		1WXM 2MSE
Enriched GO Terms of Interacting Partners?
Tagcloud ?
Tagcloud (Difference) ?
Tagcloud (Intersection) ?